Investment Opportunity

The world's first rejection sensitivity dysphoria (RSD) intervention platform, addressing a crisis affecting 99% of 366 million ADHD adults globally

Raising $500K on $4M cap SAFE

Traction & Validation

366M
ADHD Adults Globally
99%
Experience RSD With Zero Existing Tools
1,300+
Clinical Coaching Sessions Validating Product
350+
Active Users & Waitlist Combined
90%
Invite-to-Use Conversion Rate
100%
Retention After First Session
$5.6B
Mental Health App Market Growing 23% Annually
$0
Raised to Date - Bootstrapped via Coaching Revenue

The Market Opportunity

First-Mover Advantage in Untapped Market

Rejection Sensitivity Dysphoria (RSD) affects 99% of ADHD adults - devastating emotional episodes that can destroy entire days from a single perceived slight. Despite affecting 366 million people globally, zero tools exist for RSD intervention.

While competitors focus on productivity and education, DOSE addresses the crisis intervention gap - tools that work when ADHD brains are in emotional dysregulation, not just when calm.

We're not building a better productivity app. We're creating an entirely new category: crisis-ready cognitive infrastructure for neurodivergent minds.

Why Now?

ADHD Awareness Explosion

Adult diagnoses ↑30% in past 5 years. Social media destigmatization creating unprecedented market expansion.

Mental Health Funding Surge

$5.6B invested in 2023. Digital therapeutics gaining FDA pathways and insurance coverage.

Technology Maturity

Cross-platform development tools enable rapid deployment. Real-time intervention now accessible.

Clinical Gap Recognition

Therapy waitlists average 3-6 months. Urgent need for immediate crisis intervention tools.

Enterprise Opportunity

Neurodiversity workplace spending ↑40% annually. Companies seeking ADHD-specific support tools.

Competitive Validation

Inflow and Numo prove ADHD digital tools market. Their limitations create opening for crisis leader.

Unique Founder-Market Fit

Steev Hodgson brings a rare combination rarely seen in mental health tech:

Clinical Validation: 1,300+ ADHD coaching sessions with 95% retention rate
Technical Execution: Self-taught developer who built 4,000+ lines of production code
Enterprise Sales: 20+ years closing deals up to $3M (CloudBees, LaunchDarkly, Berbix)
Lived Experience: ADHD diagnosis at 48 - authentic understanding of late-diagnosis adults

This clinical expertise + technical capability + business acumen combination is extremely rare and creates defensible competitive moat competitors cannot replicate.

Use of Capital

$500K Seed Round Allocation

Product Development (40% - $200K): iOS/Android native apps, HIPAA compliance, advanced RSD analytics, AI-powered pattern recognition

User Acquisition (30% - $150K): ADHD community marketing, influencer partnerships, content creation, coach network expansion

Team Expansion (20% - $100K): Technical co-founder, marketing specialist, customer success manager

Operations (10% - $50K): Legal, compliance, clinical validation studies, business infrastructure

18-Month Milestones

10K
Active Users Across B2C & Enterprise
$500K
Annual Recurring Revenue
25
Enterprise Wellness Customers
Series A
Readiness with Proven Unit Economics

Let's Talk

Interested in learning more about this investment opportunity? Review our materials and reach out to discuss.

Currently in conversations with strategic partners.